Innovation & intellectual property · 10/12/2014Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension for Parathyroid Hormone Patent
Summary
The U.S. Patent and Trademark Office has issued an order granting a second one-year interim extension for U.S. Patent No. 5,496,801, which covers a recombinant human parathyroid hormone, under 35 U.S.C. 156(d)(5).
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →